Cerebyx® (fosphenytoin) – Expanded indication
March 1, 2017 – The FDA approved Pfizer’s Cerebyx (fosphenytoin) injection for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery in pediatric patients from birth to < 17 years of age.
Top